Formulations with anti-tumour action

Abstract

Formulations with anti-tumour action containing defibrotide and at least another active ingredient as active agents.

1 . A formulation containing, as active agents, defibrotide and at least another active ingredient with anti-tumour action. 
     
     
         2 . A formulation according to  claim 1 , which is an aqueous solution. 
     
     
         3 . A formulation according to  claim 1 , which contains customary excipients and/or adjuvants. 
     
     
         4 . A formulation according to  claim 1 , wherein the other active ingredient with anti-tumour action is selected from paclitaxel, monocrotaline, BCNU, and/or cyclophosphamide. 
     
     
         5 . A formulation according to  claim 1 , constituted by two distinct formulations that can be administered separately, one containing defibrotide and the other containing the other active ingredient with anti-tumour action. 
     
     
         6 . A formulation according to  claim 1 , as a combined preparation for simultaneous, separate, or sequential administration. 
     
     
         7 . A formulation according to  claim 1 , wherein defibrotide is obtained by extraction from animal and/or vegetable tissues. 
     
     
         8 . A formulation according to  claim 1 , wherein defibrotide is obtained synthetically.